IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $665,000 | -33.4% | 7,823 | -72.3% | 0.01% | -82.9% |
| Q2 2020 | $999,000 | +258.1% | 28,191 | +113.6% | 0.04% | +78.3% |
| Q4 2019 | $279,000 | +322.7% | 13,195 | +165.6% | 0.02% | +360.0% |
| Q3 2019 | $66,000 | +3200.0% | 4,968 | +3350.0% | 0.01% | – |
| Q2 2019 | $2,000 | -71.4% | 144 | -70.4% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | +75.0% | 487 | +151.0% | 0.00% | – |
| Q3 2018 | $4,000 | -95.8% | 194 | -97.0% | 0.00% | -100.0% |
| Q1 2018 | $96,000 | +4700.0% | 6,559 | +4302.0% | 0.01% | – |
| Q4 2017 | $2,000 | -94.7% | 149 | -94.5% | 0.00% | -100.0% |
| Q3 2017 | $38,000 | +442.9% | 2,723 | +251.4% | 0.00% | +200.0% |
| Q2 2017 | $7,000 | +600.0% | 775 | +445.8% | 0.00% | – |
| Q4 2016 | $1,000 | -85.7% | 142 | -95.1% | 0.00% | -100.0% |
| Q1 2016 | $7,000 | -46.2% | 2,927 | -30.1% | 0.00% | -50.0% |
| Q4 2015 | $13,000 | +1200.0% | 4,190 | +521.7% | 0.00% | – |
| Q3 2015 | $1,000 | -95.2% | 674 | -87.2% | 0.00% | -100.0% |
| Q2 2015 | $21,000 | -46.2% | 5,270 | -47.9% | 0.00% | -60.0% |
| Q1 2015 | $39,000 | +3800.0% | 10,120 | +7077.3% | 0.01% | – |
| Q3 2014 | $1,000 | 0.0% | 141 | -61.7% | 0.00% | – |
| Q2 2014 | $1,000 | -95.0% | 368 | -92.4% | 0.00% | -100.0% |
| Q1 2014 | $20,000 | +122.2% | 4,839 | +161.3% | 0.00% | +50.0% |
| Q4 2013 | $9,000 | -35.7% | 1,852 | -17.0% | 0.00% | 0.0% |
| Q3 2013 | $14,000 | +27.3% | 2,232 | +11.6% | 0.00% | +100.0% |
| Q2 2013 | $11,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |